Alimera Sciences Receives FDA Approval To Market Alaway(TM) OTC For Up To 12 Hours Of Eye Itch Relief
Wed, 06 Dec 2006 08:00 AM EST
... Alimera Sciences Inc., an ophthalmic pharmaceutical company founded just three years ago, today announced that the U. S. Food and Drug Administration (FDA) has approved its ophthalmic solution Rx-to-OTC-switch new drug application (NDA) for Alaway(TM) (ketotifen fumarate ophthalmic solution 0.025%). [click link for full article] ...
Related Topics
- Omeprazole OTC
- Phenylephrine Eye Solution
- Carbetapentane and Chlorpheniramine
- Research
- Omeprazole capsules
- Pink Eye
- Eye Care
- Melanoma, Intraocular
- Chlorpheniramine and Carbetapentane
- Eye exercises
- Lasik Eye Surgery
- Mammography
- Eye Diseases
- Tinea Infections
- Carbetapentane and Chlorpheniramine oral suspension
- Amblyopia
- Cerivastatin - Withdrawn From The Market
- Floaters
- Eye Cancer
- Vaccine Testing & Approval

Not Signed In -

